Share
Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (in English)
U. S. Department of Commerce
(Author)
·
Createspace Independent Publishing Platform
· Paperback
Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (in English) - U. S. Department of Commerce
$ 15.19
$ 18.99
You save: $ 3.80
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Thursday, July 11 and
Friday, July 12.
You will receive it anywhere in United States between 1 and 3 business days after shipment.
Synopsis "Pharmaceutical Price Controls in OECD Countries: Implications for U.S. Consumers, Pricing, Research and Development, and Innovation (in English)"
This report details the effect of price controls imposed by various U.S. trade partners on pharmaceutical prices, R&D, innovation, and U.S. consumers. The study examined the drug price regulatory systems of 11 OECD countries. A quantitative analysis of prices, revenues, and R&D effects based on available data was also conducted for nine OECD countries. For reasons explained in the report, two of these nine countries were excluded from further consideration. The results from the remaining six countries were then extrapolated to the total patented markets of five additional OECD countries. Thus, the final estimates of the impact of price controls on R&D and innovation are based on an analysis of 11 OECD countries.
